Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Affymetrix Inc AFFX

Healthcare Diagnostics & Research


NDAQ:AFFX - Post by User

Affymetrix Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by mhoganon Jan 17, 2000 2:50pm
443 Views
Post# 1239808

RE: Summary of business

RE: Summary of business Last week Affymetrix received a broad based agreement with Novartis to supply the company with the tools it will need to develop its gene research capabilities. The Genomics sector received a big boost on Monday when Celera announced that they have nearly completed the mapping of the Human Genome. The race is on!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities